...
首页> 外文期刊>Archives of surgery. >Risky business: Identifying risk factors associated with lymphedema after breast cancer: Comment on 'Risk factors for lymphedema in a prospective breast cancer survivorship study'.
【24h】

Risky business: Identifying risk factors associated with lymphedema after breast cancer: Comment on 'Risk factors for lymphedema in a prospective breast cancer survivorship study'.

机译:有风险的业务:确定与乳腺癌后淋巴水肿相关的危险因素:评论“在一项前瞻性乳腺癌幸存者研究中淋巴水肿的风险因素”。

获取原文
获取原文并翻译 | 示例
           

摘要

Most physicians agree that lymphedema is one of the most feared complications of breast cancer treatment. Most physicians will not agree, however, on the true incidence of lymphedema, how we should measure changes in the upper extremity, what constitutes clinically significant lymphedema, and when and how we should treat lymphedema. For a condition that is reported to be highly prevalent among breast cancer survivors (7%-70%), the risk factors for developing lymphedema are not well elucidated. In addition, it has been difficult to identify populations of at-risk survivors who may benefit from early intervention.
机译:大多数医生都同意,淋巴水肿是乳腺癌治疗中最令人担忧的并发症之一。但是,大多数医生不会就淋巴水肿的真正发生率,如何测量上肢的变化,什么是临床上显着的淋巴水肿以及何时以及如何治疗淋巴水肿达成共识。对于据报道在乳腺癌幸存者中高度流行(7%-70%)的疾病,尚没有很好地阐明发生淋巴水肿的危险因素。此外,很难确定可能从早期干预中受益的高危幸存者人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号